Robotic surgery remains a widespread practice for cancer treatment while the FDA warns no evidence has been found linking these procedures to safer patient outcomes; more than 2000 migrants in US detention centers quarantined as reported cases of mumps arise; Iowa Supreme Court rules that Medicaid can not deny coverage for sex reassignment surgery.
Robotic surgery has been particularly unsuccessful in treating cervical cancer as women who underwent these procedures experienced 6 times as many deaths and 4 times as many cancer recurrences than women who underwent traditional radical hysterectomy surgeries, which typically cures patients with cervical cancer. Although it lacks FDA approval, robotic surgery is being frequently used for cancer-related treatment, The New York Times reported. Safety and success rates have shown no evidence that patients receiving robotic procedures live longer than those who undergo traditional procedures. Questions also remain concerning how well physicians have been trained to use the equipment.
Among the 50,000 migrants held in US detention centers, 2287 have been quarantined as an estimated 236 cases of mumps have been identified over the past year throughout 51 US facilities, The Hill reported. Immigration advocates have suggested that this outbreak and transmission of other infectious diseases could restrict access to legal services.
The Iowa Supreme Court recently ruled that Medicaid can provide coverage for sex reassignment surgery, The Associated Press reported. The decision reflects a lower court’s ruling where denial of coverage was found to violate the state’s 2007 Civil Rights Act that added gender identity to the list of the state’s protected classes.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More